Enveric Biosciences, Inc. Logo

Enveric Biosciences, Inc.

Develops novel small-molecule therapeutics for neuropsychiatric disorders.

ENVB | US

Overview

Corporate Details

ISIN(s):
US02362F3029 (+1 more)
LEI:
Country:
United States of America
Address:
245 FIRST STREET RIVERVIEW II 18TH FLOOR, 2142 CAMBRIDGE

Description

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
1998-07-02 06:00
AMENDMENT NO. 1 TO FORM S-3
English 41.4 KB
1998-07-01 06:00
FORM 10-Q/A
English 21.5 KB
1998-07-01 06:00
FORM 10-K, AS AMENDED
English 63.5 KB
1998-06-01 06:00
DEFINITIVE PROXY STATEMENT
English 38.6 KB
1998-05-15 06:00
FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 1998
English 24.6 KB
1998-05-15 06:00
FORM S-3
English 102.0 KB
1998-05-14 06:00
PRELIMINARY PROXY STATEMENT
English 37.6 KB
1998-04-15 06:00
FORM 10-K405 FOR PERIOD ENDED DECEMBER 31, 1997
English 69.2 KB
1998-03-31 07:00
FORM 12B-25
English 8.5 KB
1998-02-17 06:00
AMENDMENTS TO SCHEDULE 13G
English 16.2 KB
1997-11-14 06:00
FORM 10-Q DATED 9/30/97
English 29.0 KB
1997-08-14 06:00
FORM 10-Q
English 30.5 KB
1997-06-26 06:00 English 8.3 KB
1997-05-20 06:00
FORM S-8
English 19.3 KB
1997-05-15 06:00
FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 1997
English 27.5 KB

Automate Your Workflow. Get a real-time feed of all Enveric Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enveric Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enveric Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Circio Holding ASA Logo
Clinical-stage company developing circular RNA medicines and immunotherapies.
Norway
CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
A cancer diagnostics developer creating a blood test for early lung cancer detection.
United Kingdom
CIZ
CJ Bioscience Logo
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
South Korea
311690
Climb Bio, Inc. Logo
Clinical-stage biotech developing therapies for immune-mediated diseases.
United States of America
CLYM
CODEXIS, INC. Logo
A protein engineering company developing enzymes for therapeutics and life sciences.
United States of America
CDXS
COGNITION THERAPEUTICS INC Logo
Clinical-stage company developing oral therapeutics for neurodegenerative disorders.
United States of America
CGTX
Combigene AB Logo
A gene therapy company focused on neurological disorders and chronic pain.
Sweden
COMBI
Compugen Ltd. Logo
A clinical-stage company developing cancer immunotherapies using an AI platform.
Israel
CGEN
COMPUGEN LTD Logo
A clinical-stage company using AI to discover cancer immunotherapy drug targets.
United States of America
CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies and provides non-clinical CRO preclinical services.
South Korea
166480

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.